{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:03:08Z","timestamp":1767708188275,"version":"3.48.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471459"],"award-info":[{"award-number":["82471459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02280-8","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:36:18Z","timestamp":1764243378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PICALM polymorphisms are associated with susceptibility to parkinson\u2019s disease in the Northern Chinese Han population: a case-control study"],"prefix":"10.1186","volume":"19","author":[{"given":"Ran","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binghui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"5","key":"2280_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20(5):385\u201397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2.","journal-title":"Lancet Neurol"},{"issue":"10","key":"2280_CR2","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41593-018-0240-z","volume":"21","author":"PL De Jager","year":"2018","unstructured":"De Jager PL, Yang HS, Bennett DA. Deconstructing and targeting the genomic architecture of human neurodegeneration. Nat Neurosci. 2018;21(10):1310\u20137. https:\/\/doi.org\/10.1038\/s41593-018-0240-z.","journal-title":"Nat Neurosci"},{"issue":"4","key":"2280_CR3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.22615","volume":"70","author":"M Jucker","year":"2011","unstructured":"Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol. 2011;70(4):532\u201340. https:\/\/doi.org\/10.1002\/ana.22615.","journal-title":"Ann Neurol"},{"issue":"2","key":"2280_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2307\/3577336","volume":"117","author":"RW Atcher","year":"1989","unstructured":"Atcher RW, Russo A, DeGraff WG, Moore M, Grdina DJ, Mitchell JB. Halogenated pyrimidines as radiosensitizers for high-LET radiation. Radiat Res. 1989;117(2):351\u20135.","journal-title":"Radiat Res"},{"issue":"4","key":"2280_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley T, Holton JL, Gray E, Kirkham K, O\u2019Sullivan SS, Hilbig A, et al. Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of parkinson\u2019s disease patients. Acta Neuropathol. 2008;115(4):417\u201325. https:\/\/doi.org\/10.1007\/s00401-007-0336-0.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2280_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","volume":"103","author":"VN Uversky","year":"2007","unstructured":"Uversky VN. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem. 2007;103(1):17\u201337. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04764.x.","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"2280_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12031-009-9190-y","volume":"39","author":"M Riedel","year":"2009","unstructured":"Riedel M, Goldbaum O, Richter-Landsberg C. Alpha-Synuclein promotes the recruitment of Tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress. J Mol Neurosci. 2009;39(1\u20132):226\u201334. https:\/\/doi.org\/10.1007\/s12031-009-9190-y.","journal-title":"J Mol Neurosci"},{"issue":"11","key":"2280_CR8","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","volume":"42","author":"P Lei","year":"2010","unstructured":"Lei P, Ayton S, Finkelstein DI, Adlard PA, Masters CL, Bush AI. Tau protein: relevance to parkinson\u2019s disease. Int J Biochem Cell Biol. 2010;42(11):1775\u20138. https:\/\/doi.org\/10.1016\/j.biocel.2010.07.016.","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"2280_CR9","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","volume":"26","author":"O Pletnikova","year":"2005","unstructured":"Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, et al. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in lewy body diseases. Neurobiol Aging. 2005;26(8):1183\u201392. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.10.006.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"2280_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/NEN.0b013e3181f52e01","volume":"69","author":"S Baig","year":"2010","unstructured":"Baig S, Joseph SA, Tayler H, Abraham R, Owen MJ, Williams J, et al. Distribution and expression of Picalm in alzheimer disease. J Neuropathol Exp Neurol. 2010;69(10):1071\u20137. https:\/\/doi.org\/10.1097\/NEN.0b013e3181f52e01.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"2280_CR11","doi-asserted-by":"publisher","first-page":"e91242","DOI":"10.1371\/journal.pone.0091242","volume":"9","author":"I Parikh","year":"2014","unstructured":"Parikh I, Fardo DW, Estus S. Genetics of PICALM expression and alzheimer\u2019s disease. PLoS ONE. 2014;9(3):e91242. https:\/\/doi.org\/10.1371\/journal.pone.0091242.","journal-title":"PLoS ONE"},{"issue":"5506","key":"2280_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1126\/science.291.5506.1051","volume":"291","author":"MG Ford","year":"2001","unstructured":"Ford MG, Pearse BM, Higgins MK, Vallis Y, Owen DJ, Gibson A, et al. Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science. 2001;291(5506):1051\u20135. https:\/\/doi.org\/10.1126\/science.291.5506.1051.","journal-title":"Science"},{"issue":"7","key":"2280_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nn.4025","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, et al. Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance. Nat Neurosci. 2015;18(7):978\u201387. https:\/\/doi.org\/10.1038\/nn.4025.","journal-title":"Nat Neurosci"},{"issue":"4","key":"2280_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"issue":"42","key":"2280_CR15","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1073\/pnas.1315110110","volume":"110","author":"Y Tian","year":"2013","unstructured":"Tian Y, Chang JC, Fan EY, Flajolet M, Greengard P. Adaptor complex AP2\/PICALM, through interaction with LC3, targets alzheimer\u2019s APP-CTF for terminal degradation via autophagy. Proc Natl Acad Sci U S A. 2013;110(42):17071\u20136. https:\/\/doi.org\/10.1073\/pnas.1315110110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2280_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00401-020-02125-x","volume":"139","author":"K Ando","year":"2020","unstructured":"Ando K, De Decker R, Vergara C, Yilmaz Z, Mansour S, Suain V, et al. Picalm reduction exacerbates Tau pathology in a murine Tauopathy model. Acta Neuropathol. 2020;139(4):773\u201389. https:\/\/doi.org\/10.1007\/s00401-020-02125-x.","journal-title":"Acta Neuropathol"},{"issue":"25","key":"2280_CR17","doi-asserted-by":"publisher","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","volume":"287","author":"Q Xiao","year":"2012","unstructured":"Xiao Q, Gil SC, Yan P, Wang Y, Han S, Gonzales E, et al. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. J Biol Chem. 2012;287(25):21279\u201389. https:\/\/doi.org\/10.1074\/jbc.M111.338376.","journal-title":"J Biol Chem"},{"key":"2280_CR18","unstructured":"Nikolai Vasil\u2019evich Sklifosovskii. Vestn Khir Im I I Grek. 1979;122(4):2."},{"issue":"3","key":"2280_CR19","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3233\/JAD-201046","volume":"79","author":"H Kumon","year":"2021","unstructured":"Kumon H, Yoshino Y, Funahashi Y, Mori H, Ueno M, Ozaki Y, et al. PICALM mRNA expression in the blood of patients with neurodegenerative diseases and geriatric depression. J Alzheimers Dis. 2021;79(3):1055\u201362. https:\/\/doi.org\/10.3233\/JAD-201046.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2280_CR20","first-page":"191","volume":"1","author":"SL Rosenthal","year":"2012","unstructured":"Rosenthal SL, Wang X, Demirci FY, Barmada MM, Ganguli M, Lopez OL, et al. Beta-amyloid toxicity modifier genes and the risk of alzheimer\u2019s disease. Am J Neurodegener Dis. 2012;1(2):191\u20138.","journal-title":"Am J Neurodegener Dis"},{"key":"2280_CR21","doi-asserted-by":"publisher","first-page":"24480","DOI":"10.1038\/srep24480","volume":"6","author":"W Xu","year":"2016","unstructured":"Xu W, Wang HF, Tan L, Tan MS, Tan CC, Zhu XC, et al. The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum. Sci Rep. 2016;6:24480. https:\/\/doi.org\/10.1038\/srep24480.","journal-title":"Sci Rep"},{"issue":"4","key":"2280_CR22","doi-asserted-by":"publisher","first-page":"e59676","DOI":"10.1371\/journal.pone.0059676","volume":"8","author":"LS Elias-Sonnenschein","year":"2013","unstructured":"Elias-Sonnenschein LS, Helisalmi S, Natunen T, Hall A, Paajanen T, Herukka SK, et al. Genetic loci associated with Alzheimer\u2019s disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort. PLoS One. 2013;8(4):e59676. https:\/\/doi.org\/10.1371\/journal.pone.0059676.","journal-title":"PLoS One"},{"issue":"1","key":"2280_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/s0897-1897(95)80240-1","volume":"8","author":"EV Morse","year":"1995","unstructured":"Morse EV, Simon PM, Besch CL, Walker J. Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations. Appl Nurs Res. 1995;8(1):8\u201314. https:\/\/doi.org\/10.1016\/s0897-1897(95)80240-1.","journal-title":"Appl Nurs Res"},{"issue":"3","key":"2280_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181\u20134. https:\/\/doi.org\/10.1136\/jnnp.55.3.181.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2280_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00415-016-8370-2","volume":"264","author":"J Li","year":"2017","unstructured":"Li J, Jin M, Wang L, Qin B, Wang K. MDS clinical diagnostic criteria for Parkinson\u2019s disease in China. J Neurol. 2017;264(3):476\u201381. https:\/\/doi.org\/10.1007\/s00415-016-8370-2.","journal-title":"J Neurol"},{"issue":"2\u20133","key":"2280_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12017-017-8444-z","volume":"19","author":"CB Santos-Reboucas","year":"2017","unstructured":"Santos-Reboucas CB, Goncalves AP, Dos Santos JM, Abdala BB, Motta LB, Laks J, et al. rs3851179 polymorphism at 5\u2019 to the PICALM gene is associated with alzheimer and Parkinson diseases in Brazilian population. Neuromolecular Med. 2017;19(2\u20133):293\u20139. https:\/\/doi.org\/10.1007\/s12017-017-8444-z.","journal-title":"Neuromolecular Med"},{"issue":"1","key":"2280_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10048-025-00817-8","volume":"26","author":"F Duarte-Zambrano","year":"2025","unstructured":"Duarte-Zambrano F, Alfonso-Cedeno DF, Barrero JA, Rodriguez-Vanegas LA, Moreno-Cardenas V, Olarte-Diaz A, et al. Genetic variants associated with idiopathic parkinson\u2019s disease in Latin america: A systematic review. Neurogenetics. 2025;26(1):43. https:\/\/doi.org\/10.1007\/s10048-025-00817-8.","journal-title":"Neurogenetics"},{"issue":"11","key":"2280_CR28","doi-asserted-by":"publisher","first-page":"e26952691","DOI":"10.1016\/j.neurobiolaging.2013.05.022","volume":"34","author":"SJ Chung","year":"2013","unstructured":"Chung SJ, Jung Y, Hong M, Kim MJ, You S, Kim YJ, et al. Alzheimer\u2019s disease and parkinson\u2019s disease genome-wide association study top hits and risk of parkinson\u2019s disease in Korean population. Neurobiol Aging. 2013;34(11):e26952691\u20132697. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.05.022.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"2280_CR29","doi-asserted-by":"publisher","first-page":"e24211","DOI":"10.1371\/journal.pone.0024211","volume":"6","author":"J Gao","year":"2011","unstructured":"Gao J, Huang X, Park Y, Hollenbeck A, Chen H. An exploratory study on CLU, CR1 and PICALM and Parkinson disease. PLoS One. 2011;6(8):e24211. https:\/\/doi.org\/10.1371\/journal.pone.0024211.","journal-title":"PLoS One"},{"issue":"10","key":"2280_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3109\/00207454.2012.697083","volume":"122","author":"K Kalinderi","year":"2012","unstructured":"Kalinderi K, Bostantjopoulou S, Katsarou Z, Clarimon J, Fidani L. Lack of association of the PICALM rs3851179 polymorphism with parkinson\u2019s disease in the Greek population. Int J Neurosci. 2012;122(10):502\u2013605. https:\/\/doi.org\/10.3109\/00207454.2012.697083.","journal-title":"Int J Neurosci"},{"key":"2280_CR31","doi-asserted-by":"publisher","first-page":"e217219","DOI":"10.1016\/j.neurobiolaging.2015.11.024","volume":"39","author":"YQ Wang","year":"2016","unstructured":"Wang YQ, Tang BS, Yang Y, Cui YT, Kang JF, Liu ZH, et al. Relationship between alzheimer\u2019s disease GWAS-linked top hits and risk of parkinson\u2019s disease with or without cognitive decline: a Chinese population-based study. Neurobiol Aging. 2016;39:e217219\u2013211. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.11.024.","journal-title":"Neurobiol Aging"},{"issue":"Pt 6","key":"2280_CR32","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ. Relationships between age and late progression of parkinson\u2019s disease: a clinico-pathological study. Brain. 2010;133(Pt 6):1755\u201362. https:\/\/doi.org\/10.1093\/brain\/awq059.","journal-title":"Brain"},{"issue":"3","key":"2280_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1212\/01.wnl.0000171344.87802.94","volume":"65","author":"RA Popat","year":"2005","unstructured":"Popat RA, Van Den Eeden SK, Tanner CM, McGuire V, Bernstein AL, Bloch DA, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology. 2005;65(3):383\u201390. https:\/\/doi.org\/10.1212\/01.wnl.0000171344.87802.94.","journal-title":"Neurology"},{"issue":"11","key":"2280_CR34","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1212\/wnl.62.11.2010","volume":"62","author":"P Ragonese","year":"2004","unstructured":"Ragonese P, D\u2019Amelio M, Salemi G, Aridon P, Gammino M, Epifanio A, et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology. 2004;62(11):2010\u20134. https:\/\/doi.org\/10.1212\/wnl.62.11.2010.","journal-title":"Neurology"},{"issue":"9","key":"2280_CR35","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jagp.2019.03.002","volume":"27","author":"D Weintraub","year":"2019","unstructured":"Weintraub D, Mamikonyan E. The neuropsychiatry of Parkinson disease: a perfect storm. Am J Geriatr Psychiatry. 2019;27(9):998\u20131018. https:\/\/doi.org\/10.1016\/j.jagp.2019.03.002.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"2280_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in parkinson\u2019s disease. Mov Disord. 2005;20(10):1255\u201363. https:\/\/doi.org\/10.1002\/mds.20527.","journal-title":"Mov Disord"},{"issue":"11","key":"2280_CR37","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","volume":"67","author":"C Ballard","year":"2006","unstructured":"Ballard C, Ziabreva I, Perry R, Larsen JP, O\u2019Brien J, McKeith I, et al. Differences in neuropathologic characteristics across the lewy body dementia spectrum. Neurology. 2006;67(11):1931\u20134. https:\/\/doi.org\/10.1212\/01.wnl.0000249130.63615.cc.","journal-title":"Neurology"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02280-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:58:56Z","timestamp":1767707936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-025-02280-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2280"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02280-8","relation":{},"ISSN":["1755-8794"],"issn-type":[{"type":"electronic","value":"1755-8794"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The research protocol was approved by the Ethics Committee of the Affiliated Hospital of Qingdao University (Ethic Approval Number: ZYFY-WZLL-29301), and all of the participants provided signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}